Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Apatinib|DRUG: Paclitaxel|DRUG: Carboplatin
Sponsor: Chinese Academy of Medical Sciences